Konieczny MT - Search Results

1

Rational design, synthesis and biological evaluation of thiadiazinoacridines: a new class of antitumor agents.

Antonini I, Polucci P, Magnano A, Cacciamani D, Konieczny MT, Paradziej-Łukowicz J, Martelli S. Antonini I, et al. Among authors: konieczny mt. Bioorg Med Chem. 2003 Feb 6;11(3):399-405. doi: 10.1016/s0968-0896(02)00442-x. Bioorg Med Chem. 2003. PMID: 12517435

2

Structural factors affecting affinity of cytotoxic oxathiole-fused chalcones toward tubulin.

Konieczny MT, Buɬakowska A, Pirska D, Konieczny W, Skladanowski A, Sabisz M, Wojciechowski M, Lemke K, Pieczykolan A, Strożek W. Konieczny MT, et al. Eur J Med Chem. 2015 Jan 7;89:733-42. doi: 10.1016/j.ejmech.2014.10.075. Epub 2014 Oct 30. Eur J Med Chem. 2015. PMID: 25462279

3

Acid-catalyzed synthesis of oxathiolone fused chalcones. Comparison of their activity toward various microorganisms and human cancer cells line.

Konieczny MT, Konieczny W, Sabisz M, Skladanowski A, Wakieć R, Augustynowicz-Kopeć E, Zwolska Z. Konieczny MT, et al. Eur J Med Chem. 2007 May;42(5):729-33. doi: 10.1016/j.ejmech.2006.12.014. Epub 2007 Jan 9. Eur J Med Chem. 2007. PMID: 17300856

4

Influence of S-Oxidation on Cytotoxic Activity of Oxathiole-Fused Chalcones.

Konieczny MT, Buɬakowska A, Pirska D, Konieczny W, Skladanowski A, Sabisz M, Wojciechowski M, Lemke K. Konieczny MT, et al. Chem Biol Drug Des. 2016 Oct;88(4):519-33. doi: 10.1111/cbdd.12776. Epub 2016 May 20. Chem Biol Drug Des. 2016. PMID: 27198732

5

Synthesis of isomeric, oxathiolone fused chalcones, and comparison of their activity toward various microorganisms and human cancer cells line.

Konieczny MT, Konieczny W, Sabisz M, Skladanowski A, Wakieć R, Augustynowicz-Kopeć E, Zwolska Z. Konieczny MT, et al. Chem Pharm Bull (Tokyo). 2007 May;55(5):817-20. doi: 10.1248/cpb.55.817. Chem Pharm Bull (Tokyo). 2007. PMID: 17473478 Free article.

6

Synthesis and cytostatic activity of 4,7-dihydroxythioaurone derivatives. Effect of B ring substitution on the activity.

Konieczny MT, Konieczny W, Okabe S, Tsujimoto H, Suda Y, Wierzba K. Konieczny MT, et al. Chem Pharm Bull (Tokyo). 2006 Mar;54(3):350-3. doi: 10.1248/cpb.54.350. Chem Pharm Bull (Tokyo). 2006. PMID: 16508190 Free article.

7

Structural factors affecting cytotoxic activity of (E)-1-(Benzo[d ][1,3]oxathiol-6-yl)-3-phenylprop-2-en-1-one derivatives.

Konieczny MT, Bułakowska A, Polak J, Pirska D, Konieczny W, Gryń P, Skladanowski A, Sabisz M, Lemke K, Pieczykolan A, Gałązka M, Wiciejowska K, Wietrzyk J. Konieczny MT, et al. Chem Biol Drug Des. 2014 Jul;84(1):86-91. doi: 10.1111/cbdd.12296. Epub 2014 Feb 28. Chem Biol Drug Des. 2014. PMID: 24476543

8

Antifungal action of the oxathiolone-fused chalcone derivative.

Łącka I, Konieczny MT, Bułakowska A, Rzymowski T, Milewski S. Łącka I, et al. Among authors: konieczny mt. Mycoses. 2011 Sep;54(5):e407-14. doi: 10.1111/j.1439-0507.2010.01936.x. Epub 2010 Jul 18. Mycoses. 2011. PMID: 21910757

9

Chemosensitization of multidrug resistant Candida albicans by the oxathiolone fused chalcone derivatives.

Ła̧cka I, Konieczny MT, Bułakowska A, Kodedová M, Gašková D, Maurya IK, Prasad R, Milewski S. Ła̧cka I, et al. Among authors: konieczny mt. Front Microbiol. 2015 Aug 5;6:783. doi: 10.3389/fmicb.2015.00783. eCollection 2015. Front Microbiol. 2015. PMID: 26300857 Free PMC article.

10

Pharmacokinetic Studies of Oxathio-Heterocycle Fused Chalcones.

Okoniewska K, Konieczny MT, Lemke K, Grabowski T. Okoniewska K, et al. Among authors: konieczny mt. Eur J Drug Metab Pharmacokinet. 2017 Feb;42(1):49-58. doi: 10.1007/s13318-016-0320-y. Eur J Drug Metab Pharmacokinet. 2017. PMID: 26815590

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page